| Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma ZM Jilkova, AZ Kuyucu, K Kurma, STA Pour, GS Roth, G Abbadessa, Y Yu, ... Oncotarget 9 (13), 11145, 2018 | 41 | 2018 |
| Efficacy of AKT inhibitor ARQ 092 compared with sorafenib in a cirrhotic rat model with hepatocellular carcinoma GS Roth, Z Macek Jilkova, A Zeybek Kuyucu, K Kurma, ST Ahmad Pour, ... Molecular Cancer Therapeutics 16 (10), 2157-2165, 2017 | 32 | 2017 |
| In vitro Evaluation of Doxorubicin‐Incorporated Magnetic Albumin Nanospheres A Zeybek, G Şanlı‐Mohamed, G Ak, H Yılmaz, ŞH Şanlıer Chemical Biology & Drug Design 84 (1), 108-115, 2014 | 14 | 2014 |
| Effect of novel AKT inhibitor Vevorisertib as single agent and in combination with Sorafenib on hepatocellular carcinoma in a cirrhotic rat model K Kurma, A Zeybek Kuyucu, GS Roth, N Sturm, M Mercey-Ressejac, ... International Journal of Molecular Sciences 23 (24), 16206, 2022 | 9 | 2022 |
| Abstract B111: Efficacy of AKT inhibitor ARQ 092 compared with Sorafenib in a cirrhotic rat model with hepatocellular carcinoma GS Roth, A Zeybek, Z Macek-Jilkova, G Abbadessa, Y Yu, P Marche, ... Molecular Cancer Therapeutics 14 (12_Supplement_2), B111-B111, 2015 | 1 | 2015 |
| Pre-clinical trial treatment of hepatocellular carcinoma on cirrhosis in a rat model AZ Kuyucu PQDT-Global, 2017 | | 2017 |
| AKT inhibitor ARQ 092 and sorafenib additively inhibit progression of hepatocellular carcinoma and improve immune system in cirrhotic rat model ZM Jilkova, AZ Kuyucu, K Kurma, STA Pour, GS Roth, G Abbadessa, Y Yu, ... Journal of Hepatology 66 (1), S641, 2017 | | 2017 |
| Pre-trial of hepatocellular carcinoma on cirrhosis in a rat model A Zeybek Université Grenoble Alpes; İzmir Yüksek Teknoloji Enstitüsü (Izmir, Turquie), 2016 | | 2016 |
| Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma G Roth, Z Macek-Jilkova, A Zeybek, G Abbadessa, Y Yu, P Marche, ... Journal of Hepatology 2 (64), S564-S565, 2016 | | 2016 |
| Folat ile Hedeflendirilmiş Doksorubisin Konjugatının Prostat Kanseri Hücreleri Üzerindeki Etkinliğinin Araştırılması G Ak, A Zeybek, ŞH Şanlıer, GŞ Mohamed | | |
